Immucell Corp (ICCC)

Immucell Corp Azioni (ICCC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	30.62%7.19	10.36	7.63	5.51	6.44
Cost Of Revenue	16.68%4.75	5.70	4.72	3.14	3.63
Gross Profit	47.67%2.44	4.66	2.91	2.36	2.82
	81.31%0.50	2.69	2.97	2.34	2.25
Research and Development	62.34%0.12	0.32	0.76	0.69	0.83
Operating Income/Loss	1.75%1.93	1.97	-0.06	0.02	0.57
Nonoperating Income/Loss	257.73%-0.05	-0.02	-2.79	-0.16	-0.07
Income/Loss From Continuing Operations Before Tax	3.76%1.88	1.95	-2.85	-0.14	0.50
Income Tax Expense/Benefit	266.95%0.05	0.01	0.00	0.00	0.00
	5.51%1.83	1.94	-2.85	-0.14	0.50
Attributable To Parent	5.51%1.83	1.94	-2.85	-0.14	0.50
Available To Common Stockholders, Basic	5.51%1.83	1.94	-	-0.14	0.50
Basic Average Shares	0.21%9.06	9.05	-	9.05	9.03
Diluted Average Shares	1.58%9.19	9.05	-	9.05	9.03
Basic Earnings Per Share	4.76%0.20	0.21	-	-0.02	0.06
Diluted Earnings Per Share	4.76%0.20	0.21	-	-0.02	0.06